If you've been tracking FDA Form 483 trends lately, you've probably noticed the headlines: "FDA Increases Inspections," "Common 483 Findings for 2026," and "Top Compliance Deficiencies to Avoid." These reports offer a surface-level view of what's happening in the regulatory landscape: a valuable starting point, but hardly the full story. At CompliantQS, we believe in […]